These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 840378)

  • 21. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid desensitization of presynaptic dopamine autoreceptors during exposure to exogenous dopamine.
    Arbilla S; Nowak JZ; Langer SZ
    Brain Res; 1985 Jun; 337(1):11-7. PubMed ID: 4005600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of reserpine on the arrest reaction in stimulation of the caudate nucleus in cats].
    Kosheleva OV
    Farmakol Toksikol; 1975; 38(6):650-2. PubMed ID: 1227909
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
    McKenzie GM; Szerb JC
    J Pharmacol Exp Ther; 1968 Aug; 162(2):302-8. PubMed ID: 4385909
    [No Abstract]   [Full Text] [Related]  

  • 27. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
    Klawans HL; Margolin DI; Dana N; Crosset P
    J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
    Johnels B
    Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 31. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 32. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.
    Besson M; Cheramy A; Feltz P; Glowinski J
    Brain Res; 1971 Sep; 32(2):407-24. PubMed ID: 4400012
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
    Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A
    Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancement of effects of dopaminergic agonists on neuronal activity in the caudate-putamen of the rat following long-term d-amphetamine administration.
    Rebec GV; Groves PM
    Pharmacol Biochem Behav; 1976 Sep; 5(3):349-57. PubMed ID: 996066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of acetylcholine and dopamine on the caudate nucleus depleted of biogenic amines.
    Spehlmann R
    Brain; 1975 Jun; 98(2):219-30. PubMed ID: 1148816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):71-81. PubMed ID: 4280019
    [No Abstract]   [Full Text] [Related]  

  • 40. Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus.
    Giorguieff MF; Le Floc'h ML; Westfall TC; Glowinski J; Besson MJ
    Brain Res; 1976 Apr; 106(1):117-31. PubMed ID: 1268701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.